These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33341307)

  • 1. Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant.
    Zhao X; Zeng X; Dai Q; Hou Y; Zhu D; Wang M; Jia R; Chen S; Liu M; Yang Q; Wu Y; Zhang S; Huang J; Ou X; Mao S; Gao Q; Zhang L; Liu Y; Yu Y; Cheng A
    Vaccine; 2021 Jan; 39(3):588-595. PubMed ID: 33341307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of an immune evasion gene,
    Allen JC; Natta SS; Nasrin S; Toapanta FR; Tennant SM
    Front Immunol; 2024; 15():1376734. PubMed ID: 38911854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
    Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
    PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced immunogenicity of a live
    Allen JC; Toapanta FR; Baliban SM; Sztein MB; Tennant SM
    Front Immunol; 2023; 14():1190339. PubMed ID: 37207226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.
    Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T
    Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
    Łaniewski P; Baek CH; Roland KL; Curtiss R
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine.
    Shippy DC; Fadl AA
    BMC Microbiol; 2012 Nov; 12():286. PubMed ID: 23194372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
    Piao HH; Tam VT; Na HS; Kim HJ; Ryu PY; Kim SY; Rhee JH; Choy HE; Kim SW; Hong Y
    J Microbiol; 2010 Aug; 48(4):486-95. PubMed ID: 20799091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletions in
    Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
    Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.
    Higginson EE; Ramachandran G; Panda A; Shipley ST; Kriel EH; DeTolla LJ; Lipsky M; Perkins DJ; Salerno-Goncalves R; Sztein MB; Pasetti MF; Levine MM; Tennant SM
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
    Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
    BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy against
    Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
    Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
    Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
    Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
    Zhao X; Liang S; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Yang Q; Wu Y; Zhang S; Zhang L; Liu Y; Yu Y; Cheng A
    Vaccine; 2018 Aug; 36(33):5010-5019. PubMed ID: 30017143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.